Biofunctional characteristics of in situ and invasive breast carcinoma

Is there ‘progression through grade’ in ductal invasive breast cancer?

(2012) Barbara Schymik et al.   BREAST CANCER RESEARCH AND TREATMENT

Long-Term Outcome in Patients With Ductal Carcinoma In Situ Treated With Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies

(2012) Simona F. Shaitelman et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A Study to investigate the role of p27 and Cyclin E immunoexpression as a prognostic factor in early breast carcinoma

(2011) Komala Pillay et al.   World Journal of Surgical Oncology

p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients

(2010) Maria Stendahl et al.   INTERNATIONAL JOURNAL OF CANCER

Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome

(2009) C Charpin et al.   BRITISH JOURNAL OF CANCER

Chromosomal Alterations Associated with the Transition from In Situ to Invasive Breast Cancer

(2008) Rachel E. Ellsworth et al.   ANNALS OF SURGICAL ONCOLOGY